A detailed history of Dafna Capital Management LLC transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Dafna Capital Management LLC holds 112,414 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
112,414
Previous 121,351 7.36%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
N/A
-8,937 Reduced 7.36%
112,414 $0
Q2 2024

Aug 14, 2024

SELL
N/A
-10,000 Reduced 7.61%
121,351 $0
Q4 2023

Feb 14, 2024

BUY
N/A
54,499 Added 70.91%
131,351 $0
Q2 2023

Aug 14, 2023

BUY
N/A
25,704 Added 50.25%
76,852 $0
Q1 2023

May 15, 2023

BUY
N/A
35,500 Added 226.87%
51,148 $0
Q4 2022

Feb 14, 2023

BUY
N/A
15,648 New
15,648 $0

Others Institutions Holding ACRV

About Acrivon Therapeutics, Inc.


  • Ticker ACRV
More about ACRV
Track This Portfolio

Track Dafna Capital Management LLC Portfolio

Follow Dafna Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.